HIGHLIGHTS
- who: Isabel Lastres-Becker and colleagues from the Department of Biochemistry, School of Medicine, Institute Teófilo Hernando for Drug Discovery, Instituto, Universidad Autónoma Madrid, , Madrid, Spain have published the Article: New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, in the Journal: Biomolecules 2022, 12, x FOR PEER REVIEW Therefore, of /2022/
- what: The authors used two different transgenic mouse models based on TDP-43 overexpression resembling either FTD or ALS to assess the status of the NRF2 signaling pathway.
- how: The authors carried out an in-depth analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.